Portugal provides unrestricted access to DAAs

Portugal approved the unrestricted use of direct-acting anti-virals for all HCV-infected individuals in early 2015, and over 5000 patients initiated treatment within one year. The average age of patients was over 50 and more than half had advanced fibrosis (F3/F4). Among those completing treatment, an SVR rate of 96.3% was observed, demonstrating the real world efficacy of treatment in an unrestricted patient population. Read more...


Polaris Observatory was developed by:  
Made possible through funding from:
John Martin Foundation

Copyright © polarisobservatory.com All rights reserved